Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Go back to Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 21.09 -0.3 (1.4%)
Previous Close $21.39    52 Week High $42.49 
Open $21.49    52 Week Low $16.64 
Day High $21.55    P/E N/A 
Day Low $21.05    EPS $-0.42 
Volume 753,931